Department of Pharmacognosy, Dr. Baba Saheb Ambedkar Technological University of Lonere, Maharashtra, India
 Mini Review   
								
																Pharmacovigilance Safety Monitoring in Clinical Trails 
																Author(s): Yashwant D. Nakhate*, Mohammed Tauqeer Sheikh, Kanchan S. Talekar and Sapana Tadas             
								
																
						 Monitoring patient safety during clinical trials is a critical component throughout the drug development life-cycle.
  Pharmaceutical sponsors must work proactively and collaboratively with all stakeholders to ensure a systematic
  approach to safety monitoring. The regulatory landscape has evolved with increased requirements for risk management
  plans, risk evaluation and minimization strategies. As the industry transitions from passive to active safety surveillance
  activities, there will be greater demand for more comprehensive and innovative approaches that apply quantitative
  methods to accumulating data from all sources, ranging from the discovery and preclinical through clinical and
  post-approval stages. Statistical methods, especially those based on the Bayesian framework, are important tools to
  help provide objectivity and rigor to the safety monitoring process... View more»